Filter By Industry
Filter By Tag

Newsroom

Igdrasol Press releases

1 - 6 of 6 Press Releases

IGDRASOL Announces Three Presentations on IG-001- paclitaxel polymeric micelle at AACR 2013
Apr 01, 2013
IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.

Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
Mar 07, 2013
Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.

IGDRASOL to present clinical data on NBN-paclitaxel at the AACR/JCA joint conference
Feb 13, 2013
IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.

IGDRASOL to present consolidated phase I data for IG-001 at AACR special conference
Jan 20, 2013
IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.

IGDRASOL to present company platform at Biotech Showcase™ 2013
Dec 26, 2012
IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

IGDRASOL To Present Personalized Paclitaxel Therapy at Molecular Medicine Conference 2012
Dec 16, 2012
Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.


Igdrasol RSS Feed